ÿþ<HTML><HEAD><TITLE>25º Congresso Brasileiro de Microbiologia </TITLE><link rel=STYLESHEET type=text/css href=css.css></HEAD><BODY aLink=#ff0000 bgColor=#FFFFFF leftMargin=0 link=#000000 text=#000000 topMargin=0 vLink=#000000 marginheight=0 marginwidth=0><table align=center width=700 cellpadding=0 cellspacing=0><tr><td align=left bgcolor=#cccccc valign=top width=550><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=3><font size=1>25º Congresso Brasileiro de Microbiologia </font></font></strong><font face=Verdana size=1><b><br></b></font><font face=Verdana, Arial,Helvetica, sans-serif size=1><strong> </strong></font></font></td><td align=right bgcolor=#cccccc valign=top width=150><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=1><font size=1>ResumoID:2589-1</font></em></font></strong></font></td></tr><tr><td colspan=2><br><br><table align=center width=700><tr><td>Área: <b>Imunologia ( Divisão E )</b><p align=justify><strong><H1>PROTECTIVE IMMUNE RESPONSES TO ENTEROPATHOGENIC ESCHERICHIA COLI STRAIN WITH A NEW RECOMBINANT BACILLUS SUBTILIS VACCINE STRAINS</H1></strong></p><p align=justify><b><u>Wilson Barros Luiz </u></b> (<i>USP</i>); <b>Juliano Domiraci Paccez </b> (<i>USP</i>); <b>Luís Carlos de Souza Ferreira </b> (<i>USP</i>)<br><br></p><b><font size=2>Resumo</font></b><p align=justify class=tres><font size=2><H1><FONT size=2 face="Arial, Helvetica, sans-serif">Recombinant <EM>Bacillus sub</EM>tilis strains have been successfully engineered to express heterologous antigens and elicit systemic and mucosal immune responses following oral administration of spores or vegetative cells to murine hosts as a potential vaccine delivery system. Intimins are outer membrane proteins expressed by enteric bacterial pathogens, such as enteropathogenic <EM>Escherichia coli</EM> (EPEC) and enteroheamorrhagic <EM>Escherichia coli</EM> (EHEC) strains, capable of inducing intestinal attachment-and-effacement (A/E) lesions of enterocytes. The intimin cell-binding domain is located within a 280-amino-acid (Int280) carboxy terminus. In this study we developed <EM>B. subtilis</EM> vaccine strains expressing beta intimin of some EPEC serotypes strains and evaluated their immunogenicity in mice following oral delivery of spores or vegetative cells. DBA/2 female mice immunized with the <EM>B. subtilis</EM> vaccine strains develop strong systemic (serum IgG) and secreted (fecal and milk sIgA) anti-intimin responses. Anti-intimin antibodies generated in vaccinated mice recognized the native protein expressed by different EPEC and EHEC strains. Anti-intimin antibodies detected in mice immunized with the recombinant <EM>B. subtilis</EM> strains interfered with tight binding and cytoskeletal organization changes and inhibited host cell binding of EPEC strains. Moreover, female mice immunized with the <EM>B. subtilis</EM> vaccine strains conferred passive protection to newborns challenged with a virulent Atypical EPEC strain and partial protection with Typical EPEC strain. The results further support the use of <EM>B. subtilis</EM> strains&nbsp;as a mucosal vaccine vehicle and add important knowledge regarding pathogenesis and vaccine development against EPEC and EHEC-associated diseases. Researsch supported by FAPESP and CNPq grants.</FONT></H1></font></p><br><b>Palavras-chave: </b>&nbsp;EPEC, Bacillus, Vaccine</td></tr></table></tr></td></table></body></html>